Mitral regurgitation: The most common heart disease in dogs (Proceedings)
The client wants to know, and will pay for, each test you perform or each drug you give, that has a reasonable expectation of making their pet feel better or live longer.
The client wants to know, and will pay for, each test you perform or each drug you give, that has a reasonable expectation of making their pet feel better or live longer.
A. Prevalence/Etiology: 72 million dogs in the US; 72 million cats in the US; 11% of each have heart disease; 85% of dogs with hearty disease have endocardiodiosis leading to mitral regurgitation. Prevalent in small, chondrodystrophic; familial; possibly 5HT-mediated; possibly related to periodontal disease.
B. Diagnosis and selection of drugs:
1. Left apical holosystolic murmur unrelated to severity. No Rx.
2. Left atrial and left ventricular enlargement related to severity.
Rx: ACE inhibitor, spironolactone, possibly beta blocker
3. Pulmonary congestion/edema: tachypnea, wheezes, subtle cough, crackles, cyanosis. Theophylline, furosemide, chlorothiazide, digitalis, pimobendan.
4. Supraventricular arrhythmias. Rx. digitalis, ....olol, diltiazem.
5. Ventricular arrhythmias. Rx. sotalol, amiodarone
Oral solution approved by the FDA for canine heart failure
November 22nd 2024Vetmedin Solution from Boehringer Ingelheim is indicated for treatment of cases caused by myxomatous mitral valve disease or dilated cardiomyopathy and is the first oral solution approved by the FDA for this use in dogs
Read More
Podcast CE: Canine cardiology: the practical guide to the mitral valve patient
July 19th 2023Learn about the prevalence of myxomatous mitral valve disease, guidelines for staging heart disease, proactive diagnostic workup, the importance of spironolactone and aldosterone blocking, and the benefits of combination therapy for improved outcomes in canine patients
Listen
